• The benzodiazepine subtype-2␣ 1 2␤ 2 1␥ 2 is expressed in P19 cells.
Introduction
The maintenance of intracellular pH is crucial for cell survival [12] . Accordingly; cells have several redundant means of sensing The ionotropic GABA type A (GABA A ) and the metabotropic GABA type B receptors mediate GABA stimulated synaptic inhibition; under certain conditions the GABA A receptors can produce a transient intracellular alkalinization. This occurs when specific subtypes of the receptor that respond to benzodiazepams assemble into functional receptors. For instance the subtype containing two ␣ 1 subunits, two ␤ 2 subunits, and one ␥ 2 subunit, the major subtype found in brain [14] is one example. But other receptor subtypes containing the ␥ 2 subunit, which is required for forming the benzodiazepine binding pocket, can also mediate this type of signaling. Thus, adding diazepam to hippocampal slices that had been previously stimulated result in a marked increase in the magnitude and extent of intracellular alkalinization [1] .
P19 neurons are shown to produce functional GABA A [5, 16] receptors. To test the hypothesis that the PRMT activities are modulated by GABA A receptor mediated intracellular alkalinization, we investigated whether GABA A agonist/antagonists were coupled downstream to protein arginine methylation using P19 cells and hippocampus slide preparation. The results of these studies, reported here suggest that GABA A receptors are linked to protein arginine methylation by pH-dependent and pH-independent pathways.
Materials and methods

Buffers and chemicals
HMTase Buffer is prepared as described [9] . PBS and SNARF-1AM were purchased from Invitrogen. Protease inhibitors were purchased from Roche. Muscimol and bicuculline were obtained from Ascent. Diazepam, and SAH were obtained from Sigma. [ 3 H]-S-Adenosyl-l-methionine 15 Ci/mmol was purchased from MP Biomedical, Inc.
Proteins, peptides and antibodies
Histone H3 and H4 were purchased from Roche Applied Biosciences. Myelin basic protein (mouse) was obtained from Sigma. NOLA1 was purchased from GenWay Biotech, Inc. Biotinylated SmD1 peptide, biotin-KREAVAGRGRGRGRGRGRGRGRGRGGPRR, was synthesized by CPC Scientific. The antibody to the ␤ subunit of the GABA A receptor, anti-dimethylarginine antibody SYM10 pAb, and anti-Histone H4(R3) SMe2 pAb were purchased from Millipore. The antibody to the ␣ 1 subunit of the GABA A receptor was purchased from GenWay Biotech, Inc. Anti-Hsp70c mAb was obtained from Stress-Gen. Anti-MAP2 antibody was from Santa Cruz, and anti-PAPB mAB was obtained from Cell Signaling.
Cell culture
P19 cells were cultured as described [19] . Differentiation of rapidly growing cultures into neuronal and glial cells was accomplished accordingly [13] . All of the results presented here correspond to cells cultured for 6-8 days in the presence or absence of 0.1 M RA.
Mice and hippocampal slices
WT and fragile X KO mice were obtained from a colony of congenic C57BL/fragile X KO mice at the New York State Institute for Basic Research (IBR) [21] . Fragile KO mice were derived by repeatedly backcrossed the FVB/N-129 hybrid mice carrying the fmri knockout mutation originally provided by B. Oostra and R. Willemsen to male C57BL (JAX). The WT control animals were littermates of fragile KO mice. The animals were treated in accordance with the principles and procedures of the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. The mice were euthanized by CO 2 asphyxiation as instructed by the local Institutional Animal Care and Use Committee at IBR.
Hippocampal slices were prepared as described [6] . Slices were perfused with artificial cerebral spinal fluid continuously bubbled with 95% O 2 /5% CO 2 to maintain the pH near 7.4. The temperature was maintained at 34 -36 • C.
RNA isolation and RT-PCR
RNA was extracted from P19 cells or mouse tissues using RNAeasy mRNA mini columns (Qiagen). One microgram of RNA was used to prepare first strand cDNA (Invitrogen). Aliquots of the cDNAs were amplified using the following primers: GABA A -␣ 1 , F-5 AGCTATACCCCTAACTTAGCCAGG and R-5 AGAAA-GCAATTCTCGGTGCAGAGGAC; GABA A -␤ 2 , F-5 TGAGATGGCCACA-TCCGAAGCAGT and R-5 CTCACGGAAGGCTGTAGTTTAGTTCA; GABA A -␥ 2S , F-5 AAGAAAAACCCTGCCCCTACCATTG and R-5 GTCTCCATAAGATTCAGCGAATAAC. Primers are based on the sequences of mouse GABA A receptor subunits ␣ 1 , ␤ 2 and ␥ 2S ; GenBank accession numbers NM 012050, NM 008070, NM 177408, respectively. Reaction products were resolved on agarose gels along with appropriate size markers.
Western blotting and immunofluorescence microscopy
Proteins were prepared from cultured cells or mouse tissues for Western blotting as described [18] . The blots were detected by primary antibody SYM10 or Hsp70c and corresponding HRPconjugated secondary antibody (Pierce), and developed using the PicoTag system (Pierce).
Cells were processed for immunohistochemistry as described [19] . The cells were incubated with designated primary antibody and then with secondary antibody (Alexa Fluor 488 or Alexa Fluor 568, Molecular Probes). Fluorescence was detected with an Eclipse 90i dual laser-scanning confocal microscope (NIKON). Images were acquired at 20-40× magnification Equivalent regions of interest (ROI) within each image are presented.
In vitro methylation assays
In vitro methylation by the endogenous methyltransferases (MTs) of the proteins in cell lysates or various substrate proteins was performed as described [20] , so was the in vitro methylation of the biotinylated-SmD1 peptide [20] .
pH-Dependent activation of P19 cells
Retinoic differentiated P19 cells were loaded with the pHsensing fluorescent dye SNARF-1AM, as described [20] . The cells were treated or not treated with diazepam (10 M), musicmol (100 M), bicuculline (60 M) or combination of them. The images were captured and the results were computed as described [20] .
Statistical analysis
One-way ANOVA and student Newman-Keuls post-hoc testing were used. 
Results
Mouse P19 cells express functional GABA A receptors
PRMT in embryonic P19 cells is shown to be modulated by intracellular alkalinization occurring through the Na + /H + antiporter [20] ; however there are other receptors whose activation can alter intracellular alkalinization. One of these is the GABA A receptor [1] . To determine whether GABA A ergic stimulation also results in altered PRMT-dependent methylation we first determined whether RA differentiated P19 cells contained functional GABA A receptors. Fig. 1A shows that P19 cells express a variety of GABA A receptor subunit mRNAs. Included among these was the ␥ 2S subunit mRNA whose expression is necessary for modulation of benzodiazepam [2, 16] and is pre-requisite for intracellular alkalinization. We next examined the expression of GABA A receptor subunit proteins by immunohistochemistry. Here we show that both undifferentiated P19 cells and differentiated P19 neurons express the essential GABA A receptor ␤ subunit and the GABA A ␣ 1 receptor subunit (Fig. 1B, top and bottom panels, respectively), which also helps mediate benzodiazepine binding. These results substantially recapitulate the previous work [5] .
As expression does not always result in function we sought a means of testing whether the GABA A receptor subunits expressed P19 cells were functional. For this we chose a fluorescence-based indicator reaction using SNARF-1AM, one of a family of dyes the ratio of whose emission wavelengths change as a function of pH [17] . Thus, treating cells with agents that result in intracellular alkalinization should lead to an increase in the ratio, F 640 /F 580 . Quite simply cells were loaded with SNARF-1AM for 30 min and the unabsorbed dye was washed out. The dye-loaded cells were then treated with the GABA A antagonist bicuculline, the modulator diazepam, or a combination of diazepam and the GABA A agonist muscimol, stimulated at a wavelength of 480 nm and the fluorescence [20] . The incorporated radioactivity was measured by liquid scintillation counting and compared to that of the untreated control extract. The ratio of treated/control for four independent experiments run in quadruplicate is shown. The asterisk and double asterisk denotes significant differences compared to the control.
intensities at 640 nm and 580 nm simultaneously recorded for 10 min. Fig. 1C shows the time averaged ratio F 640 /F 580 for these treatments from 4 representative experiments. As expected, treatment with the bicuculline had no effect on the F 640 /F 580 ratio and hence no effect upon intracellular pH. In contrast, both diazepam and diazepam with muscimol produced robust increases in F 640 /F 580 , which is consistent with the alkalinization of the intracellular milieu.
PRMT-dependent methylation is altered by diazepam and muscimol
We previously demonstrated that intracellular alkalinization via NH 4 Cl treatment led to differential changes in PRMT-mediated methylation of its substrates in the absence of changes to PRMT expression levels [20] . With a similar approach, we examined the influence GABA A receptor modulatory agents had on the methylation of particular exogenous PRMT substrates. Specifically, we treated RA differentiated P19 cells with muscimol, diazepam or bicuculline, harvested the cells and extracted the proteins. These protein extracts were then compared to untreated differentiated P19 cell extracts for their ability to methylate three exogenous proteins histone H4, NOLA1 or MBP, Fig. 2A . In addition, we examined the expression of an endogenous protein-p37 in RA differentiated P19 cells after various treatments with an antibody (SYM10) that recognizes symmetrically dimethylated arginine residues, Fig. 2B . It is clear from the data that bicuculline treatment had little to no effect on any of the substrates examined ( Fig. 2A) . In contrast, P19 cells treated with the GABA A agonist muscimol, and its modulator, diazepam resulted in substrate-specific alterations in their methylation profiles. In particular, we observed a significant decrease in muscimol-treated cell extracts to methylate histone H4, NOLA1, and MBP, Fig. 2A, top, 3rd and bottom panels respectively.
Histone H4 is known to be methylated at R3. To determine the effect of its symmetrical methylation at R3, we probed western blot of H4 methylation reactions with an antibody (anti-H4(R3) Sme2 ) that recognizes H4 when it is symmetrical methylated at R3 and the result shows that muscimol treatment had almost no effect on histone H4 symmetric dimethylation of residue R3 with respect to the control (Fig. 2A, 2nd panel) .
Diazepam alone was also found to alter the methylation of these proteins. In this case NOLA1 and MBP methylation were both elevated with respect to the control (Fig. 2A, 3rd and bottom panels, respectively). In contrast, neither the methylation of histone H4 ( Fig. 2A, top panel) , nor the symmetric dimethylation of the R3 residue of histone H4 (Fig. 2A, 2nd panel) was significantly affected by diazepam. Similarly, diazepam had no effect on the expression of the endogenous p37 when probing the western blot of diazepam-treated p19 extract with a SYM10 antibody (Fig. 2B,  top) . The combined data suggest that GABA A ergic stimulation of P19 cells does not much affect the pathway leading to symmetric demethylation, Fig. 2A, 2nd panel and Fig. 2B top panel. This agrees with previous work showing that PRMT5-dependent methylation of insect cell lysates is not greatly affected by changes in pH [20] .
Synergic effect of diazepam and muscimol on PRMT-dependent methylation
In addition to the simple exogenous substrate assay described above, we used an affinity capture a peptide methylation assay [20] to quantitatively examine the effect that GABA A ergic agents had on the methylation activity of P19 neurons, Fig. 2C . The peptide used in this assay corresponds to the RG-rich region of the spliceosomal protein SmD1 and is shown to be methylated by human recombinant PRMTs at various pHs [20] . Like all of the other exogenous substrates examined in Fig. 2A , we found that bicuculline had no effect on the SmD1 methylation (P = 0.81). However, in contrast to the other substrates methylation of the SmD1 peptide increased significantly compared to the controls in muscimol-treated cells (P = 0.046), while there was no significant change between the controls and diazepam-treated extracts (P = 0.36). In addition, we also assessed SmD1 methylation in cells that had been treated with muscimol and diazepam. As discussed above, diazepam with muscimol modulates intracellular pH in P19 neurons (Fig. 1C) . The results, shown in Fig. 2C demonstrate that while diazepam had no effect on PRMT activity, it potentiated the muscimol-induced PRMT activation as measured by SmD1 methylation (P muscimol = 0.046 versus P Diaz/muscimol = 0.001). Again, these data highlight the unique modulatory activity of these GABA A ergic agents toward various methylation substrates.
Altered PRMT activity in fragile X mouse
The results above suggested that a combination of diazepam and muscimol increased the methylation of the SmD1 peptide and that was elicited by stimulating a pH-dependent pathway in P19 neurons. To independently confirm this we sought a model system to further investigate this phenomenon. We chose to compare SmD1 methylation using a readily available mouse model of fragile X syndrome (FXS). Specifically, we applied diazepam (10 M) and muscimol (100 M) to hippocampal slices prepared from WT and Fmr1 KO mice for 15 min, and then measured SmD1 methylation levels after washout of diazepam and muscimol. The rationale for this choice is relatively straight forward. First, it has been shown in GABA A ␥ 2 subunit knockdown mice that the hippocampus is one of the most prevalent sites of ␥ 2 expression [4] . Second, GABA A metabolism is substantially mis-regulated in Fmr1 KO mice: the inhibitory neurotransmission in the amygdala is substantially disrupted [15] and the GABA A ␤ and GABA A ␦ subunits are substantially decreased [10, 11] . Third, the ␣ 1 and ␥ 2 subunit mRNA are significantly under-expressed in Fmr1 KO mice [7] . Lastly, protein arginine methylation is also altered in Fmr1 KO versus WT mice [8] . Thus, one might expect to see an increase in SmD1 methylation in WT slices treated with diazepam and muscimol and either no change or decreased SmD1 methylation in KO slices. As in the case of P19 neurons, while there was a robust increase in SmD1 . Protein extracts were subject to in vitro methylation using a SmD1 peptide as described above. The ratio of treated/untreated for the WT and KO for four independent experiments run in quadruplicate is shown. The double asterisk denotes the significant difference between the WT ratio and the KO ratio. (B) Hippocampal slices analogous to those in (A) were subject to in vitro methylation with the indicated substrates resolved by SDS-PAGE and then subject to fluorography (histone H4, NOLA1, MBP), or Western blotting (Hsp70c, p37). Note: the Hsp70c blot represents only the protein loads, it cannot be methylated. methylation in WT hippocampal slices treated with diazepam and muscimol, there was a significant decrease in KO hippocampal slices (P = 0.00134), Fig. 3A . In contrast, we found no apparent change between the WT and the FMR1 KO hippocampal slices in their ability to methylate histone H4, MBP, NOLA1 and p37 after the diazepam and muscimol treatment, Fig. 3B . Thus, these data confirm that GABA A ergic stimulation with the agonist muscimol and the modulator diazepam operates through a pH-dependent pathway to alter protein arginine methylation.
Discussion
In summary we have demonstrated in two different model systems that GABA A ergic agents can signal through both pHindependent and pH-dependent pathways to alter downstream protein arginine methylation targets. Furthermore, the pattern of changes elicited by GABA A ergic agents differ from those occurring when P19 neurons are stimulated with the depolarizing agent, NH 4 Cl [20] , demonstrating the extreme sensitivity of this bifurcated pathway toward modulation. Specifically, the changes in exogenous substrate methylation observed upon muscimol stimulation in the absence of diazepam reflect the activation of a pH-independent methylation pathway in P19 neurons (Figs. 1C and 2A and C).
GABA A receptors are heteropentameric ligand-gated Cl − ion channels that are formed from a combination of 19 different subunits derived from 7 subunit classes [14] . While receptors (2␣ 1 , 2␤ 2 , 1␥ 2 ) represent the major receptor subtype it is important to note that each GABA A receptor subtype formed gives rise to its unique set of electrophysiological and pharmacological properties. Critical for these studies is the fact that benzodiazepines like diazepam bind to a site formed from the interface between the ␣ 1-3,5 and ␥ 2 subunits and can significantly enhance the magnitude and extent intracellular alkalinization of the CA1 region of the hippocampus following electrophysiological stimulation administered to the contralateral CA3 region [1] . To address whether there were any combinatorial changes in methylation induced by the presence of muscimol and diazepam we assessed SmD1 methylation in both P19 neurons and hippocampal slices that had been treated with both agents. As shown in Figs. 2C and 3A, co-application of diazepam strengthened the muscimol-induced PRMT activity which reflects the activation of a pH-dependent methylation pathway (compare to Fig. 1C) .
Alterations in protein arginine methylation following GABA A receptor stimulation may occur for a variety of reasons as well as from changes in PRMT activity. One of these would be a change in PRMT expression. Nevertheless, we did not observe alteration on the expression levels of the primary asymmetric and symmetric PRMTs in cells treated with mucsicmol, bicuculline, diazepam and mucsicmol with diazepam. Therefore, any change in protein arginine methylation toward either endogenous or exogenous protein methylation substrates that may be observed following GABA A receptor stimulation of P19 cells probably occurs via a change in PRMT activity.
As a major inhibitory receptor in the brain, GABA A receptor is involved in regulating all aspects of brain function. Consequently, the impaired GABA A ergic-stimulated PRMT activation observed in the FMR1 KO hippocampal slices suggests PRMT contributes to the abnormal GABA A ergic transmission associated with FXS. Protein methylation can affect its interaction with other factors including proteins and RNAs and also its subcellular localization. Future studies will be directed to 1) identify the specific PRMT that is regulated by GABA A ergic pathway and affected in the mouse model of FXS and 2) compare methylation levels in normal, fragile x, and fragile x autistic patients by examining PMRT activity.
